American Gene Technologies®

In The News

Try these: Jeff GalvinHIVAmerican Gene TechnologiesPhenylketonuria

BioBuzz: American Gene Technologies Spins Off Addimmune as a Separate Company With a Focus on Curing HIV

Jun 18, 2023

Original Post in BioBuzz. By: Alex Keown Powered by promising Phase I results from its HIV gene and cell therapy, American Gene Technologies (AGT) is spinning off a new company dedicated solely to develop a cure for a disease Chief Executive Officer Jeff Galvin calls ‘insidious.”…

Read More

Washington Business Journal: Rockville’s AGT Launches Spinout Addimmune

Jun 18, 2023

Original Post in WBJ. By: Sara Gilgore Rockville’s American Gene Technologies is spinning off a new company that will look to raise millions of dollars in funding and potentially go public – with an ambitious goal of curing HIV.    The private, 16-year-old biotech, which…

Read More

My MC Media: Rockville Company Launches Spinoff Focused on Curing HIV

Jun 17, 2023

Original Post in MyMCMedia. By: Suzanne Pollak American Gene Technologies (AGT) in Rockville is ramping up efforts to develop a possible cure for HIV, announcing Friday it has launched a spinoff company that will focus exclusively on HIV, human immunodeficiency virus.   AGT CEO Jeff…

Read More

The Patch: Promising Data on Gene Cell Therapy for HIV Cure from Rockville Firm

Jun 17, 2023

Original Post in The Patch. By: Michael O’Connell American Gene Technologies, a Rockville-based biotech firm, announced on Friday that it was standing up a new company to oversee its HIV treatment project, which recently completed Phase 1 of its clinical trial.   “When we did…

Read More

MoCo 360: Rockville Biotech Company Sets Its Sights on Curing HIV

Jun 17, 2023

Original Post in MoCo 360. A Rockville gene therapy company is determined to find a cure for HIV – and recent studies suggest it might be on the right track.   American Gene Technologies, a 15-year-old company founded and run by CEO Jeff Galvin, conducted…

Read More

Morningside Maryland: Rockville Firm Reports Promising Data on Gene Cell Therapy for HIV Cure

Jun 16, 2023

Original Post in Morningside Maryland. A Rockville-based biotech firm, American Gene Technologies (AGT), has reported promising data on its gene cell therapy for HIV cure. The treatment, which involves genetically modifying a patient’s immune cells to target and eliminate HIV-infected cells, has shown significant promise…

Read More
Chief Medical Officer Marcus A. Conant, MD was interviewed on the From Lab to Launch podcast

From Lab to Launch Podcast: Pioneering Treatment of HIV with Dr. Marcus Conant

May 10, 2023

Have a listen. From Lab to Launch by Qualio Marcus A. Conant, MD is the Chief Medical Officer at American Gene Technologies. Dr. Conant is a physician who treated thousands of HIV patients in the early 80s while running the inpatient dermatology service at the…

Read More
PharmaVoice profiles American Gene Technologies and its gene therapy technology

PharmaVoice: This biotech’s ‘Microsoft’ approach could change how we see gene therapy

Mar 24, 2023

Original post on PharmaVoice.com   The company’s using a unique component-based platform to develop functional cures for diseases, including HIV.   Welcome to Biotech Spotlight, a series featuring companies that are creating breakthrough technologies and products. Today, we’re looking at American Gene Technologies and its…

Read More
POZ Magazine profiles AGT's video series The Cure Chronicles

POZ Magazine: HIV Advocates Inspire in “The Cure Chronicles”

Jan 24, 2023

Original post on Poz.com By Trent Straube Sexual molestation as a child, an abusive father, the foster care system, violent street gangs, an HIV diagnosis as a teenager. “Anything you can think of that’s bad, I’ve been through it,” says Latina HIV advocate Maria Mejia in an episode of The…

Read More
The Biotech Project Podcast Dives into the Passionate Vision of Jeff Galvin

Biotech Project Podcast: ‘It’s easy to be excited’ -Jeff Galvin on American Gene’s Unique Gene Therapy Technology

Jan 19, 2023

The Biotech Project podcast welcomes CEO and Founder of American Gene Technologies®, Jeff Galvin, onto the show to discuss the past, present, and future of the company’s mission to use the power of gene therapy to relieve human suffering from serious diseases. Hosts Scott J…

Read More

Subscribe to News Releases and News Updates

Subscribe to our news release and published article updates to be notified when we release new content!

Follow AGT on Social Media

AGT on Facebook

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment. loom.ly/96TZ0jU#HIV #celltherapy #biotech ... See MoreSee Less
View on Facebook
M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest. ... See MoreSee Less
View on Facebook
AGT CEO, Jeff Galvin, had a chat with social media influencer and HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Dive into the conversation as they shed light on the research and what lies ahead in our mission to find a cure for HIV! loom.ly/jAThqIU#HIV #hivcure #HIVresearch #clinicaltrials ... See MoreSee Less
View on Facebook
Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. loom.ly/NxSxjXk#genetics #science #Healthcare ... See MoreSee Less
View on Facebook